DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zemaira (Alpha 1-Antitrypsin) - Side Effect Reports to FDA

 
 



Index of reports > All Cases (57)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zemaira (Alpha 1-Antitrypsin) all cases. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 57   Next >>

Possible Zemaira side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-15

Patient: female

Reactions: Respiratory Tract Infection

Drug(s) suspected as cause:
Zemaira



Possible Zemaira side effects in male

Reported by a physician from United States on 2012-08-15

Patient: male, weighing 113.4 kg (249.5 pounds)

Reactions: Dyspnoea, Chills, Blood Pressure Decreased, Hyperhidrosis, Hypertension, Oxygen Saturation Decreased

Drug(s) suspected as cause:
Zemaira

Other drugs received by patient: Banophen (Diphenhydramine Hydrochloride); Centrum Ultra MEN (Centrm / 00554501 / ); Zyrtec; Hydrochlorothiazide; Celebrex; Lipitor; Lisinopril



Possible Zemaira side effects in 45 year old female

Reported by a pharmacist from United States on 2012-08-13

Patient: 45 year old female, weighing 104.3 kg (229.5 pounds)

Reactions: Tooth Loss, Weight Decreased, Anxiety, Dyspnoea, Vomiting, Nausea, Pulmonary Arterial Hypertension, Oxygen Saturation Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zemaira
    Dosage: (60 mg/kg 1x/week, 953 mg vial intravenous (not otherwise specified))
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2009-01-01

Zemaira
    Dosage: (60 mg/kg 1x/week, 953 mg vial intravenous (not otherwise specified))
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2012-03-01
    End date: 2012-03-01

Other drugs received by patient: Biotin; Xopenex; Singulair; Oxygen; Symbicort; Vitamin D; Digestive Probiotic (Lactobacillus Acidophilus); Alprazolam; Xanax; Protonix; Ipratropium Bromide; Albuterol; Codeine Sulfate; Combivent; Levothyroxine Sodium



Possible Zemaira side effects in female

Reported by a individual with unspecified qualification from United States on 2012-08-06

Patient: female

Reactions: Chills, Pyrexia, Device Related Infection

Drug(s) suspected as cause:
Zemaira

Aralast Alpha-1-Antitrypsin)
    Start date: 2010-06-01
    End date: 2010-08-01



Possible Zemaira side effects in male

Reported by a physician from United States on 2012-07-19

Patient: male

Reactions: Dizziness, Blood Glucose Increased

Drug(s) suspected as cause:
Zemaira

Other drugs received by patient: Spiriva; Darvocet-N 100; Robitussin DM (Robitussin); Zyrtec; Tylenol P (Paracetamol); Albuterol; Singulair; Lidoderm; Zetia; Advair HFA



Possible Zemaira side effects in male

Reported by a individual with unspecified qualification from United States on 2012-07-16

Patient: male

Reactions: Lung Disorder, Dizziness, Unevaluable Event, Blood Glucose Increased

Drug(s) suspected as cause:
Zemaira



Possible Zemaira side effects in

Reported by a individual with unspecified qualification from United States on 2012-07-06

Patient:

Reactions: Circumstance or Information Capable of Leading To Medication Error, Medication Error, Product Packaging Quantity Issue

Drug(s) suspected as cause:
Zemaira



Possible Zemaira side effects in 40 year old female

Reported by a pharmacist from United States on 2012-07-06

Patient: 40 year old female, weighing 59.0 kg (129.7 pounds)

Reactions: Product Colour Issue, Discomfort, Infusion Related Reaction

Drug(s) suspected as cause:
Zemaira



Possible Zemaira side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-02

Patient: female

Reactions: Chills, Device Related Infection, Pyrexia

Drug(s) suspected as cause:
Zemaira
    Start date: 2010-08-01

Aralast NP
    Start date: 2010-07-01
    End date: 2010-08-01



Possible Zemaira side effects in 54 year old female

Reported by a physician from United States on 2012-05-29

Patient: 54 year old female, weighing 72.6 kg (159.7 pounds)

Reactions: Hospitalisation, Adverse Event

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zemaira

Other drugs received by patient: Benadryl; Trazodone HCL; Multivitamin (Multivitamin / 00831701 / ); Lamictal; Sodium Chloride 0.9%; Fluoxetine



Possible Zemaira side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-15

Patient: female

Reactions: Chest Discomfort, Pneumonia, Dyspnoea, Muscle Spasms

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zemaira



Possible Zemaira side effects in 53 year old female

Reported by a consumer/non-health professional from United States on 2012-05-03

Patient: 53 year old female

Reactions: Hyperventilation, Dyspnoea, Paraesthesia

Drug(s) suspected as cause:
Zemaira



Possible Zemaira side effects in male

Reported by a physician from United States on 2012-04-23

Patient: male, weighing 97.5 kg (214.6 pounds)

Reactions: Vomiting, Nausea, Peritoneal Dialysis, Headache, Infusion Related Reaction

Drug(s) suspected as cause:
Zemaira
    Indication: Alpha-1 Anti-Trypsin Deficiency

Zemaira
    Dosage: 80 mg/kg 1x/week, 990 mg vial intravenous (not otherwise specified)
    Indication: Alpha-1 Anti-Trypsin Deficiency

Zemaira
    Indication: Alpha-1 Anti-Trypsin Deficiency

Zemaira
    Dosage: 80 mg/kg 1x/week, 80 mg/kg weekly 15 minute total infusion time intravenous (not otherwise specifie
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2009-05-20

Other drugs received by patient: Cellcept; Folic Acid; Protonix; Amitriptyline HCL (Amitriptyline); Oxycodone HCL and Acetaminophen; Lantis (Insulin Glargine); BL Ferrous SU (Ferrous Sulfate); Prograff (Tacrolimus); Prochlorperazine; Prednisone; Calcium 600 D (Calcium with Vitamin D); Actos; Humalog; Lisinopril; Sodium Bicarbonate; Glipizide; Simvastatin



Possible Zemaira side effects in 61 year old female

Reported by a pharmacist from United States on 2012-04-02

Patient: 61 year old female, weighing 143.8 kg (316.3 pounds)

Reactions: Pneumonia, Cellulitis, Concomitant Disease Aggravated, Chronic Respiratory Failure, Chronic Obstructive Pulmonary Disease, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zemaira
    Dosage: (952 mg/vial; 952 mg/20 ml intravenous (not otherwise specified))
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2012-01-01

Zemaira
    Dosage: (952 mg/vial; 952 mg/20 ml intravenous (not otherwise specified))
    Indication: Emphysema
    Start date: 2012-01-01

Zemaira
    Dosage: (60 mg/kg 1x/week, 945 mg/vial;max rate=0.08 ml/kg/min (11.6 ml/min) intravenous (not otherwise spe
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2007-01-01

Zemaira
    Dosage: (60 mg/kg 1x/week, 945 mg/vial;max rate=0.08 ml/kg/min (11.6 ml/min) intravenous (not otherwise spe
    Indication: Emphysema
    Start date: 2007-01-01

Zemaira
    Indication: Emphysema
    Start date: 2012-03-14

Zemaira
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2012-03-14

Other drugs received by patient: Sodium Chloride; Singulair; Vitamin D; Lasix; Prinzide; Cardizem; Zocor; Metformin HCL; Advair HFA; Ibuprofen (Advil); Multivitamin (Accomin Multivitamin); Ipratropium Albuterol (Salbutamol W / Ipratropium)



Possible Zemaira side effects in 54 year old female

Reported by a physician from United States on 2012-03-15

Patient: 54 year old female, weighing 78.9 kg (173.6 pounds)

Reactions: Productive Cough, Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zemaira
    Indication: Alpha-1 Anti-Trypsin Deficiency

Zemaira
    Dosage: 60 mg/kg 1x/week, at rate of 0.08 ml per kg per minute intravenous (not otherwise specified)
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2010-04-01

Zemaira
    Dosage: 60 mg/kg 1x/week, 0.08 ml /kg/min intravenous (not otherwise specified))
    Start date: 2012-02-28

Other drugs received by patient: Thiamine HCL; Pulmicort; Singulair; Multivitamin (Daily Multivitamin); Foradil; Albuterol; Protonix; Zaroxolyn; Heparin; Nexium; Prednisone TAB; Lasix (Insulin Glargine); Diltiazem HCL; Lantus; Flexeril; Spiriva; Vitamin B12 (Cyanocobalamin-Tannin Complex); Digoxin; Doxycycline



Possible Zemaira side effects in 54 year old female

Reported by a pharmacist from United States on 2012-03-14

Patient: 54 year old female, weighing 72.6 kg (159.7 pounds)

Reactions: Hospitalisation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zemaira

Other drugs received by patient: Trazodone HCL; Benadryl; Fluoxetine; Sodium Chloride; Multi-Vitamin; Lamictal



Possible Zemaira side effects in 58 year old female

Reported by a pharmacist from United States on 2012-03-14

Patient: 58 year old female, weighing 82.0 kg (180.4 pounds)

Reactions: Cellulitis, Sinusitis, Respiratory Tract Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zemaira
    Dosage: intravenous (not otherwise specified)
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-06-01

Zemaira
    Dosage: 60 mg/kg 1x/week intravenous otherwise specified)
    Indication: Alpha-1 Anti-Trypsin Deficiency

Zemaira
    Dosage: 60 mg/kg 1x/week intravenous (not otherwise specified,
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2007-02-01

Zemaira
    Dosage: intravenous (not otherwise specified
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-04-01

Zemaira
    Dosage: 869 mg vial; max rate of 0.08 ml./kg/min (3 ml/min) intravenous (not otherwise specified)
    Indication: Alpha-1 Anti-Trypsin Deficiency

Zemaira
    Dosage: 60 mg/kg 1x/week
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2007-01-01

Other drugs received by patient: Oxygen; Aspirin; Lutein (Xantofyl); Fosamax; Prednisone; Azmacort Inhaler (Triamcinolone Acetonide); Xanax; Sodium Chloride; Albuterol; Ibuprofen; Multivitamin (Accomin Multivitamin); Spiriva; Acetaminophen; Pneumovax 23; Doxycycline Hyclate



Possible Zemaira side effects in 49 year old female

Reported by a pharmacist from United States on 2012-03-14

Patient: 49 year old female, weighing 62.6 kg (137.7 pounds)

Reactions: Fatigue, Upper Respiratory Tract Infection, Pulmonary Arterial Hypertension, Somnolence, Respiratory Tract Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zemaira
    Dosage: 60 mg/kg 1x/7 days intravenous (not otherwise specified)
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2009-11-01

Zemaira
    Dosage: intravenous (not otherwise specified))
    Indication: Alpha-1 Anti-Trypsin Deficiency

Other drugs received by patient: Sodium Chloride; Doxepin HCL; Xopenex HFA (Levosalbutamol); Zyban; Estradiol; Lisinopril; Oxygen; Spiriva; Prednisone TAB; Advair 250 (Seretide); Albuterol



Possible Zemaira side effects in male

Reported by a pharmacist from United States on 2012-03-02

Patient: male, weighing 73.5 kg (161.7 pounds)

Reactions: Asthma, Respiratory Tract Congestion, Chest Pain, Oxygen Saturation Decreased

Drug(s) suspected as cause:
Zemaira
    Dosage: see image
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2010-01-01

Zemaira
    Dosage: see image
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2010-01-01

Zemaira

Other drugs received by patient: Zyrtec; Singulair; Sodium Chloride 0.9%; Prednisone TAB; Flovent; Spiriva; Nasacort; Levaquin



Possible Zemaira side effects in 58 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-15

Patient: 58 year old female, weighing 82.0 kg (180.4 pounds)

Reactions: Cellulitis, Skin Infection, Respiratory Tract Infection, Sinusitis

Drug(s) suspected as cause:
Zemaira
    Dosage: 60;869;0.08; 3mg 1xweek, intravenous
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-04-01

Zemaira
    Dosage: 60;869;0.08; 3mg 1xweek, intravenous
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2007-02-01

Zemaira
    Dosage: 60;869;0.08; 3mg 1xweek, intravenous
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-06-01

Zemaira
    Dosage: 60;869;0.08; 3mg 1xweek, intravenous
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2007-01-01

Zemaira

Zemaira

Other drugs received by patient: Fosamax; Prednisone TAB; Albuterol; Xanax; Pneumovax 23; Ibuprofen; Multivitamin (Accomin Multivitamin); Azmacort Inhaler (Triamcinolone Acetonide; Lutein (Xantofyl); Oxygen (Oxygen); Spiriva; Acetaminophen; Aspirin; Sodium Chloride 0.9%



Possible Zemaira side effects in 61 year old female

Reported by a pharmacist from United States on 2012-02-15

Patient: 61 year old female, weighing 144.7 kg (318.3 pounds)

Reactions: Pneumonia, Cellulitis, Condition Aggravated, Chronic Obstructive Pulmonary Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zemaira

Zemaira
    Dosage: 60 mg/kg 1/week, 945 mg/vial, max rate = 0.08 ml/kg/min (11.6 ml /min intravenous (not otherwise spe
    Indication: Emphysema

Zemaira
    Dosage: 60 mg/kg 1/week, 945 mg/vial, max rate = 0.08 ml/kg/min (11.6 ml /min intravenous (not otherwise spe
    Indication: Alpha-1 Anti-Trypsin Deficiency

Other drugs received by patient: Sodium Chloride 0.9%; Singulair; Cardizem; Oxygen (Oxygen); Ibuprofen (Advil); Lasix; Advair HFA; Multivitamin (Accomin Multivitamin); Vitamin D; Ipratropium Albuterol (Salbutamol W / Ipratropium); Zocor; Metformin HCL; Prinzide



Possible Zemaira side effects in 56 year old female

Reported by a physician from United States on 2012-01-23

Patient: 56 year old female, weighing 72.6 kg (159.7 pounds)

Reactions: Respiratory Tract Congestion, Viral Upper Respiratory Tract Infection, Nasopharyngitis, Condition Aggravated, Sinusitis, Chronic Obstructive Pulmonary Disease, Lower Respiratory Tract Infection

Drug(s) suspected as cause:
Zemaira
    Dosage: see image
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2011-10-13

Zemaira
    Dosage: see image
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-10-13

Zemaira
    Dosage: see image
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2012-01-05

Zemaira
    Dosage: see image
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2012-01-05

Zemaira
    Dosage: see image
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2009-08-01

Zemaira
    Dosage: see image
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2009-08-01

Zemaira

Zemaira

Zemaira

Other drugs received by patient: Mucinex; Singulair; Lisinopril; Advair Diskus 100 / 50; Lexapro; Estrace; PRO AIR (Procaterol Hydrochloride); Prinivil; Spiriva; Activella (Oestranorm)



Possible Zemaira side effects in 61 year old female

Reported by a physician from United States on 2012-01-23

Patient: 61 year old female, weighing 91.2 kg (200.6 pounds)

Reactions: Contusion, Angioedema, Pain in Extremity, Condition Aggravated, Nasal Congestion, Musculoskeletal Chest Pain, Headache, Oral Pruritus, Fall, Oral Discomfort, Pruritus Generalised, Fatigue, Limb Injury, Dizziness, Infusion Related Reaction

Drug(s) suspected as cause:
Zemaira

Zemaira

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-01-26

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2011-01-26

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-03-31

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2011-03-31

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-02-20

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2011-02-20

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-05-05

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2011-05-05

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-01-28

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2011-01-28

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2011-01-26

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2011-01-26

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2010-11-01

Zemaira
    Dosage: (60 mg/kg 1x/week, 1012 mg vials; 60 mg/kg infused over 30 minutes intravenous (not otherwise specif
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2010-11-01

Zemaira

Zemaira

Zemaira

Other drugs received by patient: Novolog; Protonix; Sodium Chloride 0.9%; Ibuprofen; Xanax; Levothyroxine Sodium; Vitamin B12; Novolog; Celexa; Lantus; Atenolol; Albuterol; Multivitamin (Accomin Multivitamin); Vitamin D; Gabapentin; Cardizem



Possible Zemaira side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-20

Patient: male, weighing 110.0 kg (242.0 pounds)

Reactions: Chest Discomfort, Pharyngeal Disorder, Dizziness, Headache, Infusion Related Reaction

Drug(s) suspected as cause:
Zemaira

Other drugs received by patient: Ascorbic Acid; Losartan Potassium; Symbicort; Combivent; PRE MED Benadril; Amlodipine



Possible Zemaira side effects in 56 year old female

Reported by a physician from United States on 2012-01-18

Patient: 56 year old female, weighing 72.6 kg (159.7 pounds)

Reactions: Upper Respiratory Tract Infection, Sinusitis

Drug(s) suspected as cause:
Zemaira
    Dosage: see image
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2009-08-01

Zemaira
    Dosage: see image
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2009-08-01

Zemaira

Zemaira

Zemaira

Other drugs received by patient: Singulair; PRO AIR (Procaterol Hydrochloride); Advair HFA; Prinivil; Mucinex; Lexapro; Spiriva; Activella (Oestranorm); Estrace; Lisinopril



Possible Zemaira side effects in 68 year old female

Reported by a pharmacist from United States on 2012-01-18

Patient: 68 year old female, weighing 66.2 kg (145.7 pounds)

Reactions: Vomiting, Nausea, Lower Respiratory Tract Infection, Infusion Related Reaction

Drug(s) suspected as cause:
Zemaira
    Dosage: see image
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2010-11-22

Zemaira
    Dosage: see image
    Indication: Emphysema
    Start date: 2010-11-22

Zemaira
    Start date: 2010-11-22

Zemaira
    Start date: 2010-11-22

Other drugs received by patient: Calan; Benzonatate; Xanax; Advair HFA; Orphenadrine Citrate; Zyrtec; Pravastatin; Lyrica; Avapro; Maxzide; Oxygen; Multivitamin Accomin Multivitamin); Sodium Chloride; Albuterol



Possible Zemaira side effects in 50 year old female

Reported by a pharmacist from United States on 2012-01-18

Patient: 50 year old female, weighing 45.4 kg (99.8 pounds)

Reactions: Lung Infection

Drug(s) suspected as cause:
Zemaira
    Dosage: (60 mg/kg 1x/week,869 mg/20 ml vial;0.08 ml/kg/min(3.7 ml/min.) intravenous(not otherwise specified)
    Indication: Blood Disorder
    Start date: 2005-04-01

Zemaira
    Dosage: (60 mg/kg 1x/week,869 mg/20 ml vial;0.08 ml/kg/min(3.7 ml/min.) intravenous(not otherwise specified)
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2005-04-01

Other drugs received by patient: Sodium Chloride; Heparin; Symbicort; Albuterol; Oxygen; Protonix; Vitamin D; Aspirin; Spiriva; Singulair



Possible Zemaira side effects in 74 year old female

Reported by a physician from United States on 2012-01-12

Patient: 74 year old female, weighing 69.9 kg (153.7 pounds)

Reactions: Pruritus, Urticaria, Rash, Kidney Infection

Drug(s) suspected as cause:
Zemaira

Zemaira
    Dosage: see image
    Indication: Alpha-1 Anti-Trypsin Deficiency
    Start date: 2007-05-21

Zemaira
    Dosage: see image
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2007-05-21

Other drugs received by patient: Prednisone TAB; Evista; Lorazepam; Doxepin HCL; Theo-24 ER (Theophylline); Allegra; Multivitamin (Accomin Multivitamin); Pataday (Olopatadine Hydrochloride); Lisinopril; Qvar 40; Kenalog; Potassium Chloride; Furosemide; Actonel; Albuterol; Calcium Carbonate; Heparin; Prevacid; Theratears (Carmellose)



Possible Zemaira side effects in 56 year old male

Reported by a physician from United States on 2012-01-06

Patient: 56 year old male, weighing 70.3 kg (154.7 pounds)

Reactions: Myalgia, Syncope, Bone Pain, Dizziness, Feeling Abnormal, Chest X-RAY Abnormal, Loss of Consciousness, Infusion Related Reaction

Drug(s) suspected as cause:
Zemaira

Zemaira
    Dosage: (intravenous (not otherwise specified)), (60 mg/kg 1x/week, approx. 30-60 minutes; 0.08 ml/kg/min (5
    Indication: Obstructive Airways Disorder
    Start date: 2011-03-25

Zemaira
    Dosage: (intravenous (not otherwise specified)), (60 mg/kg 1x/week, approx. 30-60 minutes; 0.08 ml/kg/min (5
    Indication: Obstructive Airways Disorder
    Start date: 2011-11-04
    End date: 2011-11-04

Zemaira
    Dosage: (intravenous (not otherwise specified)), (60 mg/kg 1x/week, approx. 30-60 minutes; 0.08 ml/kg/min (5
    Indication: Obstructive Airways Disorder
    Start date: 2011-01-01

Zemaira

Other drugs received by patient: Symbicort; Daliresp; Spiriva; Proventil; Mucinex



Possible Zemaira side effects in male

Reported by a physician from United States on 2011-12-28

Patient: male, weighing 113.4 kg (249.5 pounds)

Reactions: Dyspnoea, Chills, Hypertension, Hyperhidrosis

Drug(s) suspected as cause:
Zemaira

Other drugs received by patient: Centrum Ulta MEN (Centrum / 00554501 / ); Lisinopril; Lipitor (Atorvastain Calcium); Celebrex (Celeboxib); Hydrochlorothiazide; Zyrtec; Banophen (Diphenhydramine Hydrochloride)



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017